WHO Guidelines for pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses: part II review of evidence
Année de publication: 2010
This revised guidance is published in two parts. Part II documents the procedures followed in developing this guidance, together with a review of evidence and other new information on the pharmacological agents considered.
Pandemics, Influenza A Virus, H1N1 Subtype, Influenza, Human/drug therapy, RNA Virus Infections/drug therapy, Oseltamivir/administration & dosage, Zanamivir/administration & dosage, Amantadine/administration & dosage, Rimantadine/administration & dosage, Ribavirin/administration & dosage, Antiviral Agents/administration & dosage